Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment

The primary goal of this study was the production of liposomes encapsulating kanamycin for drug administration by inhalation. The selected drug is indicated for multiresistant tuberculosis, and administration through inhalation allows both local delivery of the drug to the lungs and systemic therapy. The ethanol injection method used for the liposome production is easily scaled up and is characterized by simplicity and low cost. Vesicles were prepared using different lipid compositions, including hydrogenated soybean phosphatidylcholine and cholesterol (SPC/Chol), egg phosphatidylcholine and cholesterol (EPC/Chol), distearoyl phosphatidylcholine and cholesterol (DSPC/Chol), distearoyl phosphatidylcholine, dimyristoyl phosphatidylethanolamine and cholesterol (DSPC/DMPE/Chol), dipalmitoyl phosphatidylcholine and cholesterol (DPPC/Chol) and dipalmitoyl phosphatidylcholine, dipalmitoyl phosphatidylglycerol and cholesterol (DPPC/DPPG/Chol). The effects of different operational conditions for vesicle production and drug encapsulation were evaluated, aiming at a compromise between final process cost and suitable vesicle characteristics. The best performance concerning drug incorporation was achieved with the DSPC/Chol system, although its production cost was considerably larger than that of the natural lipids formulations. Encapsulation efficiencies up to 63% and final drug to lipid molar ratios up to 0.1 were obtained for SPC/Chol vesicles presenting mean diameters of 132 nm incubated at 60°C with the drug for 60 min at an initial drug‐to‐lipid molar ratio of 0.16.

[1]  H. P. Gupta,et al.  Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice , 1994, Antimicrobial Agents and Chemotherapy.

[2]  T. I. Petrenko,et al.  [Effectiveness of liposomal antibacterial drugs in the inhalation therapy of experimental tuberculosis]. , 1995, Problemy tuberkuleza.

[3]  P. Gangadharam,et al.  Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes , 1995, Antimicrobial agents and chemotherapy.

[4]  Â. M. Moraes,et al.  Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation , 2003, Drug delivery.

[5]  E. Westhof,et al.  Aminoglycoside-RNA interactions. , 1999, Current opinion in chemical biology.

[6]  K. Taylor,et al.  Liposomes for controlled delivery of drugs to the lung. , 1992, Thorax.

[7]  Sanyog Jain,et al.  Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.

[8]  P. Davies,et al.  A world-wide internet survey of public knowledge about tuberculosis. , 2002, Respiratory medicine.

[9]  R. Pandey,et al.  Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. , 2002, International journal of antimicrobial agents.

[10]  P. S. Chen,et al.  Microdetermination of Phosphorus , 1956 .

[11]  S. Franzblau,et al.  Effective Treatment of Acute and Chronic Murine Tuberculosis with Liposome-Encapsulated Clofazimine , 1999, Antimicrobial Agents and Chemotherapy.

[12]  J. Lagacé,et al.  Aerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa. , 1999, Journal of drug targeting.

[13]  M. Bally,et al.  The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. , 1990, Chemistry and physics of lipids.

[14]  M. Bally,et al.  Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. , 1990, Biochimica et biophysica acta.

[15]  P. A. Bridges,et al.  An investigation of some of the factors influencing the jet nebulisation of liposomes. , 2000, International journal of pharmaceutics.

[16]  P. Deol,et al.  Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. , 1997, Biochimica et biophysica acta.

[17]  H. Yang,et al.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice , 1997, Antimicrobial agents and chemotherapy.

[18]  K. Joshi,et al.  Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice , 1997, Antimicrobial agents and chemotherapy.

[19]  R. Carbonell,et al.  Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine. , 1999, Journal of microencapsulation.

[20]  E. Korn,et al.  Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.